BioLight Life Sciences Ltd. (TASE: BOLT)
Health Care · Life Sciences Tools & Services · IL
₪2.70
-7.10% today · -35.2% 1Y
BioLight Life Sciences Ltd. (TASE: BOLT) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $7.99M and employs 4 people.
Over the last twelve months the share price has lost 35.2%, trading between 2.09 and 4.66.
Tweenvest scores BioLight Life Sciences Ltd. across four factors: quality 49/100, value 54/100. Its strongest factor is value.
BOLT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.99M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.45
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- ₪4.66
- 52-week low
- ₪2.09
- Avg volume (3M)
- —
- Shares outstanding
- 9.08M
- Employees
- 4
- Next earnings
- —
About BioLight Life Sciences Ltd.
BioLight Life Sciences Ltd. is an ophthalmic firm dedicated to discovering, developing, and bringing to market innovative products and pipeline candidates designed to tackle various eye-related ailments. Its portfolio and development pipeline include DiagnosTear's TeaRx, a diagnostic platform analyzing tear fluid components to identify frontal eye diseases, and Peripherex, offering solutions for both at-home and clinical diagnosis and monitoring of peripheral vision loss, crucial for conditions like glaucoma. For glaucoma, BioLight features ViSci (an Eye D technology utilizing a subconjunctival implant), Belkin Vision's rapid, automated laser system for effective intraocular pressure reduction, and Sanoculis, which is advancing a novel surgical approach. The company also encompasses OphRx, focused on developing pharmaceutical treatments for ocular disorders; AEYE, which designs artificial intelligence-powered solutions for diverse retinal conditions; and Tarsier, working on TRS 01, a platform-based treatment for uveitis in patients with elevated intraocular pressure. Founded in 2005, the Tel Aviv, Israel-based company operated as Bio Light Israeli Life Sciences Investments Ltd. until its rebranding to BioLight Life Sciences Ltd. in February 2016.
- ISIN
- IL0010952237
- Founded
- 2005
- Listed since
- Dec 27, 2005
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Health Group Inc.SEHK: 8225 | $10.02M | HK$0.08 | +12.86% |
| RBC Bioscience CorporationTPEX: 6848 | $9.55M | NT$21.40 | -0.23% |
| IDL Diagnostics AB (publ)OM: IDLDX | $8.89M | Skr0.39 | +4.32% |
| PhoenixBio Co., Ltd.TSE: 6190 | $8.17M | ¥318.00 | +1.27% |
| Medicofarma Biotech SAWSE: MDB | $6.52M | zł0.38 | +0.53% |
| Ghani Global Glass LimitedKASE: GGGL | $6.48M | PKRs7.51 | -0.27% |
| Proteome Sciences plcAIM: PRM | $6.29M | £0.01 | +0.37% |
| Reflect Scientific, Inc.OTCPK: RSCF | $4.70M | $0.05 | +15.38% |
Figures last refreshed Oct 11, 2026.